EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 111 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $777,439 | -83.1% | 113,994 | +129.8% | 0.00% | -100.0% |
Q1 2021 | $4,609,000 | +390.3% | 49,611 | +373.0% | 0.00% | – |
Q4 2020 | $940,000 | -97.5% | 10,488 | -97.1% | 0.00% | -100.0% |
Q3 2020 | $37,011,000 | +83.5% | 358,178 | +40.4% | 0.01% | +100.0% |
Q2 2020 | $20,174,000 | +5647.6% | 255,117 | +4100.8% | 0.00% | – |
Q1 2020 | $351,000 | -86.1% | 6,073 | -87.0% | 0.00% | -100.0% |
Q4 2019 | $2,530,000 | +46.3% | 46,891 | +78.6% | 0.00% | – |
Q3 2018 | $1,729,000 | -70.1% | 26,262 | -77.1% | 0.00% | -100.0% |
Q2 2018 | $5,791,000 | +8.1% | 114,692 | +12.7% | 0.00% | 0.0% |
Q1 2018 | $5,357,000 | +33.9% | 101,750 | +18.2% | 0.00% | 0.0% |
Q4 2017 | $4,000,000 | +353.5% | 86,063 | +294.9% | 0.00% | – |
Q3 2017 | $882,000 | +19.4% | 21,795 | 0.0% | 0.00% | – |
Q2 2017 | $739,000 | -41.4% | 21,795 | -49.9% | 0.00% | – |
Q1 2017 | $1,262,000 | -61.7% | 43,470 | -56.7% | 0.00% | -100.0% |
Q4 2016 | $3,295,000 | -38.6% | 100,322 | -41.1% | 0.00% | 0.0% |
Q3 2016 | $5,369,000 | +16.9% | 170,260 | +4.2% | 0.00% | 0.0% |
Q2 2016 | $4,594,000 | -32.8% | 163,353 | -13.2% | 0.00% | -50.0% |
Q1 2016 | $6,839,000 | -11.5% | 188,150 | -2.6% | 0.00% | 0.0% |
Q4 2015 | $7,732,000 | +81.0% | 193,243 | +28.9% | 0.00% | +100.0% |
Q3 2015 | $4,271,000 | +24.4% | 149,943 | +43.9% | 0.00% | 0.0% |
Q2 2015 | $3,433,000 | +141.8% | 104,176 | +111.0% | 0.00% | – |
Q1 2015 | $1,420,000 | +26.9% | 49,361 | +20.1% | 0.00% | – |
Q4 2014 | $1,119,000 | -32.6% | 41,095 | -47.2% | 0.00% | – |
Q3 2014 | $1,660,000 | -11.1% | 77,900 | -6.4% | 0.00% | -100.0% |
Q2 2014 | $1,868,000 | -63.5% | 83,188 | -58.9% | 0.00% | 0.0% |
Q1 2014 | $5,111,000 | +17.5% | 202,288 | +6.9% | 0.00% | 0.0% |
Q4 2013 | $4,350,000 | +44.7% | 189,188 | +19.9% | 0.00% | 0.0% |
Q3 2013 | $3,006,000 | +93.2% | 157,788 | +46.3% | 0.00% | 0.0% |
Q2 2013 | $1,556,000 | – | 107,861 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |